medac GmbH
Jan-Oliver Kahl is an experienced professional in the field of regulatory affairs, currently serving as Manager of Global Regulatory Affairs - New Products at medac GmbH since September 2022. Prior to this role, Jan-Oliver Kahl gained practical experience in global regulatory affairs during a traineeship at medac GmbH from November 2021 to April 2022 and as a pharmacist intern at Alte Apotheke Selsingen in 2021. Jan-Oliver Kahl's educational background includes a Staatsexamen in Pharmacy from Technische Universität Braunschweig (2015-2020), a Basic Course in Drug Regulatory Affairs from the University of Augsburg (September 2022 - October 2022), and ongoing studies towards a Master's degree in Drug Regulatory Affairs at The University of Bonn (August 2023 - February 2025).
This person is not in the org chart
medac GmbH
We are a privately held, medium-sized global pharmaceutical and diagnostics company based in Germany. For more than 50 years we have been committed to high quality products, reliable supply and individual customer services. Today, over 2.000 medac employees worldwide are working together to supply more than 90 countries with our products. Since our foundation we have been specialising in the treatment of oncological, haematological, urological, and autoimmune diseases. Today, we are a leading specialist supplier in oncology and rheumatology. We combine the innovative power of a researching pharmaceutical company with the efficiency of a generics manufacturer and offer both therapeutics and diagnostics. Always putting the needs of patients and healthcare professionals first, we are committed to the refinement of established and the development of new products with additional benefits for patients in specific niche indications with high therapeutic needs.